We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Monitoring Cancer and Drug Delivery with Nanoparticles

By MedImaging International staff writers
Posted on 09 Dec 2014
A new type of nanoparticle has been developed that can be used to perform fluorescent imaging and MRI simultaneously to help track specific molecules and targeted drug delivery, and monitor the environment around a tumor.

The researchers used the nanoparticles in mice to track the movement and concentration of vitamin C by comparing the fluorescence and MRI contrast of the nanoparticles at different locations. The nanoparticles were assembled from separate polymer chains carrying either a nitroxide organic MRI contrast agent, or the fluorescent molecule Cy5.5. The chains were combined in a ratio of 99% nitroxides and 1% Cy5.5. Normally, the lifetime of the nitroxide is too short to obtain useful MRI images but was extended by the researchers by attaching the nitroxide to branched bottlebrush polymers architectures. Using this technique the researchers created nanoparticles carrying three different drugs and also the fluorescent agent.

According to Jeremiah A. Johnson, assistant professor of Chemistry at MIT and senior author of the study, "Someday you might be able to inject this into a patient and obtain real-time biochemical information about disease sites and also healthy tissues." The research was carried out at the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) by a team of researchers and was published in the November 18, 2014, issue of Nature Communications.

Related Links:

MIT


Portable X-ray Unit
AJEX140H
Adjustable Mobile Barrier
M-458
High-Precision QA Tool
DEXA Phantom
Half Apron
Demi

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.